AI system beats radiologists at predicting lung cancer riskA deep learning AI system was able to detect malignant lung nodules better than radiologists in a new Share XAI system beats radiologists at predicting lung cancer riskhttps://pharmaphorum.com/news/ai-system-beats-radiologists-at-predicting-lung-cancer-risk/
Merck & Co to buy cancer biotech Peloton for $2.2bnMerck & Co is to buy the privately-held biotech Peloton for up to $2.2 billion, adding further oncology Share XMerck & Co to buy cancer biotech Peloton for $2.2bnhttps://pharmaphorum.com/news/merck-co-to-buy-cancer-biotech-peloton-for-2-2bn/
UDG Healthcare acquires Putnam Associates and Incisive HealthUDG Healthcare has boosted its Ashfield Communications and Advisory business with a brace of deals, acquiring Putnam Associates Share XUDG Healthcare acquires Putnam Associates and Incisive Healthhttps://pharmaphorum.com/news/udg-healthcare-putnam-incisive-health/
Patient Insights: Severe psoriasis & eczemaHoward Chang has lived with severe psoriasis and atopic dermatitis for almost 40 years since childhood. Now a Share XPatient Insights: Severe psoriasis & eczemahttps://pharmaphorum.com/views-analysis-patients/patient-insights-severe-psoriasis-eczema/
Oncology round-up: AZ and Daiichi score key trial win with breast cancer antibody and moreAZ and Daiichi Sankyo announced positive top-line results from the pivotal phase 2 DESTINY-Breast01 trial of trastuzumab deruxtecan, Share XOncology round-up: AZ and Daiichi score key trial win with breast cancer antibody and morehttps://pharmaphorum.com/views-and-analysis/oncology-round-up-az-and-daiichi-score-key-trial-win-with-breast-cancer-antibody-and-more/
US healthcare reform scenarios and their impact on the systemIn an effort to control healthcare costs, provide healthcare to the uninsured and underinsured, and improve health outcomes, Share XUS healthcare reform scenarios and their impact on the systemhttps://deep-dive.pharmaphorum.com/magazine/access-and-commercialisation/icon-us-healthcare-reform-scenarios/
US healthcare reform scenarios and their impact on the systemIn an effort to control healthcare costs, provide healthcare to the uninsured and underinsured, and improve health outcomes, Share XUS healthcare reform scenarios and their impact on the systemhttps://deep-dive.pharmaphorum.com/magazine/access-and-commercialisation/icon-us-healthcare-reform-scenarios/
China in the fast laneBrett Gardiner and Boon Yap from Research Partnership discuss access opportunities for novel therapies in the world’s hottest Share XChina in the fast lanehttps://deep-dive.pharmaphorum.com/magazine/access-and-commercialisation/research-partnership-pharma-market-access-china/
Developing with start-up DNAAs head of digital at Sandoz, Andre Heeg is at the forefront of transformation both within his company Share XDeveloping with start-up DNAhttps://deep-dive.pharmaphorum.com/magazine/access-and-commercialisation/sandoz-andre-heeg-digital-startups/
Orphan medicines launch excellence: sustaining launch success Share XOrphan medicines launch excellence: sustaining launch successhttps://pharmaphorum.com/market-access-2/orphan-medicines-launch-excellence-sustaining-launch-success/
Navigating new frontiers: Ways to find space in the future RA market Share XNavigating new frontiers: Ways to find space in the future RA markethttps://pharmaphorum.com/r-d/navigating-new-frontiers-ways-to-find-space-in-the-future-ra-market/
The 2nd Life Sciences Sector Deal and the NHS 10 Year Plan Share XThe 2nd Life Sciences Sector Deal and the NHS 10 Year Planhttps://pharmaphorum.com/market-access-2/the-2nd-life-sciences-sector-deal-and-the-nhs-10-year-plan/
A blueprint for healthcare: Brand strategy and planningWhen pharmaceutical and biotech companies are working on their brand strategy and conducting brand planning it is vital Share XA blueprint for healthcare: Brand strategy and planninghttps://pharmaphorum.com/sales-marketing/a-blueprint-for-healthcare-brand-strategy-and-planning/
Breaking new ground in digital content delivery for pharmaIt’s all too easy for pharmaceutical processes to slow marketing campaigns, rendering them unmanageable and ineffective, but a Share XBreaking new ground in digital content delivery for pharmahttps://pharmaphorum.com/sales-marketing/breaking-new-ground-in-digital-content-delivery-for-pharma/
Good data supports pharma sales reps to drive lead generationAllow pharma sales reps to focus on the job in hand by making sure they have access to Share XGood data supports pharma sales reps to drive lead generationhttps://pharmaphorum.com/sales-marketing/good-data-supports-pharma-sales-reps-to-drive-lead-generation/
AMR research and Matoke Pharma: the pharmaphorum podcast Share XAMR research and Matoke Pharma: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/amr-research-matoke-pharma-podcast/
The future of pharma in a digital world Share XThe future of pharma in a digital worldhttps://pharmaphorum.com/digital/healthlive-the-future-of-pharma-in-a-digital-world/
Raising the bar in liver cancer therapy Share XRaising the bar in liver cancer therapyhttps://pharmaphorum.com/oncology/insights-oncology/raising-bar-liver-cancer-therapy/
Registration is now open for the inaugural Wearable Injectors Conference 2019 Share XRegistration is now open for the inaugural Wearable Injectors Conference 2019https://pharmaphorum.com/partner-content/registration-is-now-open-for-the-inaugural-wearable-injectors-conference-2019/
Cleanroom industry experts join the Pharma Cleanroom Technology Conference in October Share XCleanroom industry experts join the Pharma Cleanroom Technology Conference in Octoberhttps://pharmaphorum.com/partner-content/cleanroom-industry-experts-join-the-pharma-cleanroom-technology-conference-in-october/
UK Electronic Health Records Market will achieve 4.5% CAGR up to 2025 Share XUK Electronic Health Records Market will achieve 4.5% CAGR up to 2025https://pharmaphorum.com/partner-content/uk-electronic-health-records-market-will-achieve-4-5-cagr-up-to-2025/
Surgical Robots Market value will expand at 24% CAGR up to 2025 Share XSurgical Robots Market value will expand at 24% CAGR up to 2025https://pharmaphorum.com/partner-content/surgical-robots-market-value-will-expand-at-24-cagr-up-to-2025/
pharmaphorum welcomes George Underwood to its editorial helm Share Xpharmaphorum welcomes George Underwood to its editorial helmhttps://pharmaphorum.com/news/pharmaphorum-welcomes-george-underwood-to-its-editorial-helm/
STEM Healthcare appoints Jason McKenna as CEO Share XSTEM Healthcare appoints Jason McKenna as CEOhttps://pharmaphorum.com/partner-content/stem-healthcare-appoints-jason-mckenna-as-ceo/
